{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:09:46Z","timestamp":1788473386577,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.013","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T01:08:15Z","timestamp":1657156095000},"page":"4897-4904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term persistence of antibodies after diphtheria\/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls"],"prefix":"10.1016","volume":"40","author":[{"given":"Johannes","family":"Mischlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika K.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger B.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Ann","family":"Siegrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Villiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silja","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2022.06.013_b0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.06.013_b0010","unstructured":"Sanofi Pasteur. Product Information Tenivac Package Insert, Tetanus and Diphtheria Toxoids Adsorbed n.d. https:\/\/www.fda.gov\/media\/76610\/download (accessed March 3, 2020)."},{"key":"10.1016\/j.vaccine.2022.06.013_b0015","unstructured":"GlaxoSmithKline. Package Insert Boostrix\u2014Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine n.d. https:\/\/www.fda.gov\/media\/76633\/download (accessed March 3, 2020)."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.06.013_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","article-title":"Epidemiology of rheumatic diseases","volume":"39","author":"Sangha","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.013_b0025","article-title":"Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients","volume":"22","author":"Nived","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.013_b0030","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/ar4427","article-title":"Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis","volume":"16","author":"Kapetanovic","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.013_b0035","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar4358","article-title":"Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis","volume":"15","author":"Crnkic Kapetanovic","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.013_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-016-1082-z","article-title":"Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept","volume":"17","author":"Alten","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.013_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1 vaccination in immune-mediated disease\u2013a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vaccine.2022.06.013_b0050","doi-asserted-by":"crossref","unstructured":"B\u00fchler S, Jaeger VK, Adler S, Bannert B, Br\u00fcmmerhoff C, Ciurea A, et al. Safety and immunogenicity of tetanus\/diphtheria vaccination in patients with rheumatic diseases\u2014a prospective multi-centre cohort study. Rheumatology 2019; 58: 1585\u201396. https:\/\/doi.org\/10.1093\/rheumatology\/kez045.","DOI":"10.1093\/rheumatology\/kez045"},{"key":"10.1016\/j.vaccine.2022.06.013_b0055","unstructured":"Bundesamt fuer Gesundheit (BAG) EK fuer I. Richtlinien und Empfehlungen zu Impfungen und Prophylaxe 2020. https:\/\/www.bag.admin.ch\/bag\/de\/home\/gesund-leben\/gesundheitsfoerderung-und-praevention\/impfungen-prophylaxe\/richtlinien-empfehlungen-impfungen-prophylaxe.html (accessed March 3, 2020)."},{"key":"10.1016\/j.vaccine.2022.06.013_b0060","unstructured":"Koch-Institut R. Epidemiologisches Bulletin 02 \/ 2020 2020. https:\/\/doi.org\/http:\/\/dx.doi.org\/10.25646\/6451."},{"key":"10.1016\/j.vaccine.2022.06.013_b0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2017.04.014","article-title":"Protective and pathogenic memory plasma cells","volume":"189","author":"Hoyer","year":"2017","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.013_b0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.0105-2896.2006.00380.x","article-title":"Adaptation of humoral memory","volume":"211","author":"H\u00f6fer","year":"2006","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.013_b0075","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.013_b0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/leu.2010.320","article-title":"Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma","volume":"25","author":"Paiva","year":"2011","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.013_b0085","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2022.06.013_b0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.013_b0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.013_b0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.40831","article-title":"Risk factors associated with accelerated rubella IgG antibody loss in previously vaccinated, treatment-naive patients with juvenile systemic lupus erythematosus: A prospective study","volume":"71","author":"Maritsi","year":"2019","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"19","key":"10.1016\/j.vaccine.2022.06.013_b0105","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2019.12.042","article-title":"Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals","volume":"38","author":"Burkhard","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.013_b0110","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.vaccine.2022.06.013_b0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.vaccine.2022.06.013_b0120","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of rituximab in kidney allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"issue":"16","key":"10.1016\/j.vaccine.2022.06.013_b0125","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1182\/blood-2011-03-344051","article-title":"Immunologic effects of rituximab on the human spleen in immune thrombocytopenia","volume":"118","author":"Audia","year":"2011","journal-title":"Blood"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:41Z","timestamp":1759403921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":25,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22007605"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term persistence of antibodies after diphtheria\/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}